Summary
The biological effects, hypoglycaemic symptoms, endocrine counterregulatory responses and glucose recovery following the injection of purified porcine and human insulin preparations were compared in a number of controlled clinical investigations and prospective clinical trials. In these studies involving healthy volunteers, Type 1 (insulin-dependent) diabetic patients on continuous subcutaneous insulin infusion or intensified conventional insulin therapy and insulin treated Type 2 (non-insulin-dependent) diabetic patients, no differences with regard to biological effects, counterregulatory responses, hypoglycaemic awareness or the long-term incidence of severe hypoglycaemia between porcine and human insulin preparations were identified. These data fail to confirm any specific risk of severe hypoglycaemia attributable to the use of human insulin preparations in the treatment of patients with diabetes mellitus.
Article PDF
Avoid common mistakes on your manuscript.
References
Sonnenberg GE, Berger M (1983) Human insulin: much ado about one amino acid? Diabetologia 25: 457–459
Pickup J (1986) Human insulin. Br Med J 292: 157–159
Teuscher A, Berger GW (1987) Hypoglycaemia unawareness in diabetics transferred from beef/porcine to human insulin. Lancet ii: 382–385
Bottermann P, Gyaram H, Wahl K, Ermler R, Lebender A (1982) Insulin concentration time action profiles of different intermediate acting insulin preparations in non-diabetic volunteers under glucose controlled glucose infusion technique. Diabetes Care 5 [Suppl 2] 43–52
Heine RJ, Bilo HJG, van de Meer EA, van de Meer J (1984) Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins. Diabetologia 27: 558–562
Tsotsalas M, Mühlhauser I (1985) Miscibility of human lente insulin with soluble insulin. Diabetologia 28: 252
Schlüter KJ, Petersen KG, Sontheimer J, Enzmann F, Kerp L (1982) Different counterregulatory responses to human insulin (recombinant DNA) and purified pork insulin. Diabetes Care 5 [Suppl 2]: 78–81
Rosak C, Althoff PH, Enzmann F, Schöffling K (1982) Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man. Diabetes Care 5 [Suppl 2]: 82–89
Landgraf-Leurs MMC, Brügelmann I, Kammerer S, Lorenz R, Landgraf R (1984) Counterregulatory hormone release after human and porcine insulin in healthy subjects and patients with pituitary disorders. Klin Wochenschr 62: 659–668
Müller-Esch G, Ball P, Bekemeyer U, Heidbüchel K, Kraas E, Wood WG, Scriba PC (1983) Keine Wirkungsunterschiede zwischen biosynthetischem Humaninsulin (BHI) und Schweineinsulin (PI) im GCIIS-gesteuerten Insulinhypoglykämietest (IHT). Wien Med Wochenschr 133 [Suppl 76]: 17
Perez Fernandez R, Casanueva FF, Devesa J, Cabezas-Cerrato J (1985) Metabolic and hormonal parameters after insulin-induced hypoglycaemia in man, comparison between biosynthetic human insulin and purified pork insulin. Horm Metab Res 17: 351–354
Spraui M, Sonnenberg GE, Urbanek C, Reck-Linnenberg M, Berger M (1985) Vergleich der gegenregulatorischen Reaktionen bei Human- und Schweineinsulin-induzierten Hypoglykämien. Schweiz Med Wochenschr 115 [Suppl 18]: 40 (Abstract)
Sonnenberg GE, Chantelau EA, Sundermann S, Hauff C, Berger M (1982) Human and porcine regular insulins are equally effective in subcutaneous replacement therapy. Diabetes 31: 600–602
Berger M, Sonnenberg GE, Chantelau EA (1982) Insulin pump therapy for diabetes: some questions can be answered already. Clin Physiol 2: 351–356
Sonnenberg GE, Spraul M, Chantelau EA, Berger M (1985) Kontinuierliche subkutane Insulin-Infusionstherapie. Dtsch Med Wochenschr 110: 1859–1864
Mühlhauser I. Berger M, Sonnenberg GE, Koch J, Jörgens V, Schernthaner G, Scholz V (1985) Incidence and management of severe hypoglycaemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8: 268–273
Sonnenberg GE, Mühlhauser I, Chantelau EA, Berger M (1985) Incidence of ketoacidosis and severe hypoglycaemia in conventionally treated and CSII treated type 1 diabetic patients. Diabetes 34: 460 (Abstract)
Mühlhauser I, Jörgens V, Berger M, Graninger W, Gürtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE (1983) Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other parameters of diabetes care for up to 22 months. Diabetologia 25: 470–476
Assal JP, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M (1985) Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28: 602–613
Berger M (1985) Insulin therapy: conventional. Alberti KGMM, Krall LP (eds) Diabetes annual I. Elsevier, Amsterdam New York Oxford, pp 111–128
Berger M (1986) Insulin therapy: conventional. Alberti KGMM, Krall LP (eds) Diabetes annual II. Elsevier, Amsterdam New York Oxford, pp 69–80
Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS (1987) Defective glucose counterregulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med 316: 1376–1383
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berger, M. Human insulin: much ado about hypoglycaemia (un)awareness. Diabetologia 30, 829–833 (1987). https://doi.org/10.1007/BF00274789
Issue Date:
DOI: https://doi.org/10.1007/BF00274789